Is vaccine type seropositivity a marker for human papillomavirus vaccination? National Health and Nutrition Examination Survey, 2003–2010()

OBJECTIVE: Since 2006, human papillomavirus (HPV) vaccination has been routinely recommended for adolescent females in the USA. The quadrivalent vaccine induces long-term seropositivity to HPV 6/11/16, which may be useful as a marker for HPV vaccine coverage. METHODS: We evaluated vaccine type serop...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrosky, Emiko Y., Hariri, Susan, Markowitz, Lauri E., Panicker, Gitika, Unger, Elizabeth R., Dunne, Eileen F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659353/
https://www.ncbi.nlm.nih.gov/pubmed/25596377
http://dx.doi.org/10.1016/j.ijid.2015.01.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659353/
https://www.ncbi.nlm.nih.gov/pubmed/25596377
http://dx.doi.org/10.1016/j.ijid.2015.01.010

Ejemplares similares